Lam Research Corporation (LRCX) Balance Sheet

The sequential increase in total assets, particularly the jump to $23.5B in 2026Q4, reflects both operational growth and a rising cash position. Equity growth outpaced asset growth, suggesting improving financial health. This trajectory is consistent with the record revenue and operating margin reported in the income statement, though the EPS miss indicates some margin pressure.

The reduction in absolute debt and the D/E ratio suggests a deliberate deleveraging, possibly funded by strong cash generation. With a D/E of 0.30, LRCX is less leveraged than peers like KLAC (0.93) and AMAT (0.35), positioning it well to weather cyclical downturns. This conservative approach aligns with management's historical capital allocation priorities.

The relatively low PPE intensity underscores the company's asset-light business model, consistent with its high ROIC and strong cash conversion. Goodwill has remained stable around $1.6-1.9B, suggesting no major acquisitions, which reduces impairment risk. The asset mix supports the view that LRCX's competitive advantage lies in intellectual property and process know-how rather than physical assets.

The substantial increase in retained earnings, despite significant share repurchases and dividends, highlights the company's profitability and cash generation. The equity base has expanded by over 50% in two and a half years, providing a solid cushion for future investments and downturns. This trend is consistent with the robust cash flow and strong net income reported in prior analyses.

The current ratio, though slightly down from its peak, remains well above 2, indicating a strong liquidity position. Cash of $5.6B provides a significant buffer against cyclical downturns and supports continued capital returns. This liquidity, combined with low debt, suggests the company can navigate potential headwinds from China concentration or memory market volatility.